Famotidine Injection recalled over temperature-control failures
- Recall date
- June 17, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- HF Acquisition Co. LLC recalls Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Di…
- Recall number
- D-1392-2020
- FDA classification
- Class III
- Brand / firm
- HF Acquisition Co. LLC
- Sold / distributed
- The vials were distributed to one consignee located in CT.
Why it was recalled
TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acquisition Co, LLC, Mukilteo, WA 98275, NDC 63323-739-12
Get recall alerts
Free email alert whenever HF Acquisition Co. LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: HF Acquisition Co. LLC